Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.
about
Harnessing the immune system to improve cancer therapyProtecting the normal in order to better kill the cancerPotential role of High mobility group box 1 in hepatocellular carcinomaFractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour ResponseEffect of liver regeneration on malignant hepatic tumorsTreatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell deathInhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiationTranscriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenograftsIncreased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.The redox biology network in cancer pathophysiology and therapeuticsImplication of transcriptional repression in compound C-induced apoptosis in cancer cells.Extracellular Vesicles Mediate Radiation-Induced Systemic Bystander Signals in the Bone Marrow and Spleen.Molecular insights into the development of T cell-based immunotherapy for prostate cancer.ANTI-TUMOR IMMUNE RESPONSES INDUCED BY RADIOTHERAPY: A REVIEW.Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma.White paper on microbial anti-cancer therapy and prevention
P2860
Q26738698-63F00609-541A-447E-8AED-0FF92E02D450Q26801291-9C73B316-B8AE-4FF6-9A1E-C584DDD4EF97Q26864508-734A74EB-CBAA-4898-B49C-8CC7F2861E93Q27334088-84D16B05-ED1F-4E00-999E-597918329CFDQ28651675-6B46BDBE-00D3-4C91-BF44-5DB87BE39E00Q34227797-7A726E1B-88D2-412C-9837-2AD720702BC8Q35273555-F13FF386-FFE4-47BA-A3F4-387C32A0B8DFQ35591847-D6753B29-9BE1-48AB-BAD3-BF796EBA5133Q35624661-7ADB4771-CF13-4BED-8162-798018AC0E84Q35658529-54C61E2F-DC02-42A5-B493-3201667AD6CDQ35849711-52EBED9C-209D-46B9-8F28-EF4D829E2BC5Q37577474-8E717DA1-BADE-4794-92BB-87A6EFDAD1F6Q37721689-6EB4B5A0-5CA4-46C8-9B42-3160D160B856Q38254639-8A27366B-0969-4AF0-AFA8-622F19C340B3Q38541959-C653930D-6D03-47FE-8EB2-C4387E905753Q42037461-7BF30435-1098-44A1-A21E-D52D98EA1F76Q47401128-AC6E4383-62B4-4FB0-A6C3-FE9C194A8C3DQ48335636-2B248609-4CAE-4971-B240-0CD5F21C7ECEQ48508291-D6619CC8-A5B1-4FA1-99D0-2D82810080F7Q50072050-5391A5D4-E678-4CA0-A1E8-14EC9ECDD0C7Q55468048-2C9FD261-A250-4C09-87C6-1C639FDF2746Q55513615-C96CD9CC-C5B5-4F6C-8C89-BE09B3294EE7Q56898750-987E1675-8222-4D4B-9160-CD3325FEFB7D
P2860
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunogenic tumor cell death i ...... ms and a clinical translation.
@en
type
label
Immunogenic tumor cell death i ...... ms and a clinical translation.
@en
prefLabel
Immunogenic tumor cell death i ...... ms and a clinical translation.
@en
P2093
P2860
P356
P1476
Immunogenic tumor cell death i ...... ms and a clinical translation.
@en
P2093
P2860
P356
10.1038/CDDIS.2013.207
P5008
P577
2013-06-20T00:00:00Z